NovoCure director Timothy Scannell retires from board effective Sept 2, 2026

NovoCure Ltd

Timothy Scannell, a current director, retired from the Board effective September 2, 2026.
His seat was formally vacated pursuant to the Company's Articles of Association.
Retirement after five years of service; no disagreement with Company or management.
No replacement director named in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.